Werkgroep Cardiologische centra Nederland

STANDUP-HF (Follow-up)

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with HF and Impaired Systoli
Medicine
BMS-986231
Population
Heart failure
Phase
II
Starting year
2016